Details for Patent: RE47826
Which drugs does patent RE47826 protect, and when does it expire?
Patent RE47826 protects XARACOLL and is included in one NDA.
This patent has twenty-six patent family members in fifteen countries.
Summary for Patent: RE47826
| Title: | Drug delivery device for providing local analgesia, local anesthesia or nerve blockage |
| Abstract: | The invention relates to a drug delivery device for providing local analgesia, local anesthesia or nerve blockade at a site in a human or animal in need thereof, the device comprising a fibrillar collagen matrix; and at least one drug substance selected from the group consisting of amino amide anesthetics, amino ester anesthetics and mixtures thereof, the at least one drug substance being substantially homogeneously dispersed in the collagen matrix, and the at least one drug substance being present in an amount sufficient to provide a duration of local analgesia, local anesthesia or nerve blockade which lasts for at least about one day after administration. |
| Inventor(s): | Michael Myers, Philip Wallace Reginald |
| Assignee: | INNOCOLL PHARMACEUTICALS Ltd |
| Application Number: | US14/660,681 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; Device; |
Drugs Protected by US Patent RE47826
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Innocoll Pharms | XARACOLL | bupivacaine hydrochloride | IMPLANT;IMPLANTATION | 209511-001 | Aug 28, 2020 | DISCN | Yes | No | RE47826 | ⤷ Start Trial | A METHOD FOR INDUCING A POST-SURGICAL ANALGESIA SPARING EFFECT BY IMPLANTING AT THE SURGICAL SITE A COLLAGEN SPONGE CONTAINING BUPIVACAINE HCL WHICH PROVIDES LOCAL ANESTHESIA FOR UP TO 24 HOURS FOLLOWING IMPLANTATION | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent RE47826
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Cyprus | 1117814 | ⤷ Start Trial | |||
| Cyprus | 1121568 | ⤷ Start Trial | |||
| Germany | 202008018583 | ⤷ Start Trial | |||
| Denmark | 2139457 | ⤷ Start Trial | |||
| Denmark | 3085363 | ⤷ Start Trial | |||
| European Patent Office | 2139457 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
